- Investing Ideas
- /
- Brazilian Pharmaceuticals & Biotech Potentially Undervalued Companies
Brazilian Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED May 22, 2022
Companies with a Value score of at least 3, ordered by Value score
12 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| I1NC34Incyte | R$188.87 | 0% | n/a | R$16.6b | R$233.16 | PS17.8x | E27.7% | n/a | ||
| E2XE34Exelixis | R$42.66 | -16.7% | n/a | R$5.7b | R$63.73 | PS19.1x | E24.7% | n/a | ||
| BLAU3Blau FarmacĂȘutica | R$23.50 | 0.8% | -44.6% | R$4.2b | R$41.67 | PS14x | E17.5% | 1.1% | ||
| H1ZN34Horizon Therapeutics | R$43.86 | -3.6% | -12.6% | R$20.8b | R$69.05 | PS24.1x | E27.7% | n/a | ||
| ABBV34AbbVie | R$733.60 | -5.5% | 18.2% | R$266.9b | R$802.93 | PS21.5x | E-0.3% | 3.7% | ||
| GILD34Gilead Sciences | R$154.87 | -0.9% | -16.1% | R$80.1b | R$169.97 | PS17.7x | E8.4% | 4.6% | ||
| PFIZ34Pfizer | R$63.69 | 1.6% | 19.1% | R$294.4b | R$70.14 | PS11.6x | E-17.1% | 3.0% | ||
| REGN34Regeneron Pharmaceuticals | R$639.87 | -2.0% | 17.4% | R$71.2b | R$667.17 | PS9x | E-3.9% | n/a | ||
| MRCK34Merck | R$56.79 | -0.6% | 7.2% | R$236.6b | R$58.30 | PS17x | E13.0% | 2.9% | ||
| AMGN34Amgen | R$42.91 | -1.7% | -10.7% | R$132.2b | R$42.75 | PS23.1x | E10.7% | 3.1% | ||
| BIIB34Biogen | R$161.34 | -3.3% | -36.7% | R$29.2b | R$198.68 | PS20.2x | E2.2% | n/a | ||
| C2RS34CRISPR Therapeutics | R$32.62 | 12.8% | n/a | R$4.4b | R$69.85 | PS14x | E57.9% | n/a |
Page 1 of 1